LAMEA Biosimulation Market Size, Share & Trends Analysis Report By Product, By Pricing Model, By End Use, By Application, By Deployment Model (Cloud-based, On-premises, and Hybrid Model), By Therapeutic Area, By Country and Growth Forecast, 2024 - 2031
Published Date : 18-Dec-2024 |
Pages: 184 |
Formats: PDF |
COVID-19 Impact on the LAMEA Biosimulation Market
Market Overview
The Latin America, Middle East and Africa Biosimulation Market would witness market growth of 19.4% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Biosimulation Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $215.1 million by 2031. The Argentina market is showcasing a CAGR of 20.1% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 19.1% during (2024 - 2031).
For biosimilars, they ensures their equivalence to original biologics by simulating pharmacokinetic and pharmacodynamic (PK/PD) profiles. This reduces the need for extensive comparative trials, saving time and resources. For instance, this has been used to demonstrate the bioequivalence of insulin biosimilars, ensuring they perform identically to the original products.
While traditionally focused on pharmaceuticals, this is increasingly applied across diverse fields, significantly expanding its market scope. In the field of toxicology, this is transforming chemical safety evaluations by modeling the impacts of hazardous agents on biological systems, thereby diminishing the reliance on animal testing.
The UAE’s strategic focus on becoming a global healthcare and biotechnology hub has driven this adoption. Programs like the National Strategy for Advanced Innovation aim to integrate cutting-edge technologies into various sectors, including healthcare. Dubai Healthcare City and Abu Dhabi’s Mubadala Healthcare have partnered with global pharmaceutical companies to explore this for personalized medicine and clinical trial optimization. Additionally, the UAE’s focus on medical tourism and incorporating smart technologies into its healthcare infrastructure are key drivers of market growth. These advancements highlight the UAE’s commitment to becoming a regional leader in healthcare innovation, making it a lucrative market for biosimulation technologies. Hence, the regional market will grow rapidly in the coming years.
Free Valuable Insights: The Worldwide Biosimulation Market is Projected to reach USD 11.16 Billion by 2031, at a CAGR of 16.7%
Based on Product, the market is segmented into Software (Molecular Modeling & Simulation Software, Clinical Trial Design Software, PK/PD Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Toxicity Prediction Software, and Other Software Type) and Services (Contract Services, Consulting, and Other Services Type). Based on Pricing Model, the market is segmented into License-based Model, Subscription-based Model, Service-based Model, and Pay Per Use Model. Based on End Use, the market is segmented into Life Sciences Companies, Academic Research Institutions, and Other End Use. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling, and Other Application. Based on Deployment Model, the market is segmented into Cloud-based, On-premises, and Hybrid Model. Based on Therapeutic Area, the market is segmented into Oncology, Cardiovascular Disease, Infectious Disease, Neurological Disorders, and Other Therapeutic Area. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Certara, Inc.
- Dassault Systemes SE
- Advanced Chemistry Development, Inc.
- Genedata AG (Danaher Corporation)
- Instem Group of Companies
- Chemical Computing Group ULC
- Simulations Plus, Inc.
- Schrodinger, Inc.
- PPD, Inc. (Thermo Fisher Scientific, Inc.)
- Physiomics Plc
LAMEA Biosimulation Market Report Segmentation
By Product
- Software
- Molecular Modeling & Simulation Software
- Clinical Trial Design Software
- PK/PD Modeling and Simulation Software
- Pbpk Modeling and Simulation Software
- Toxicity Prediction Software
- Other Software Type
- Services
- Contract Services
- Consulting
- Other Services Type
By Pricing Model
- License-based Model
- Subscription-based Model
- Service-based Model
- Pay Per Use Model
By End Use
- Life Sciences Companies
- Academic Research Institutions
- Other End Use
By Application
- Drug Discovery & Development
- Disease Modeling
- Other Application
By Deployment Model
- Cloud-based
- On-premises
- Hybrid Model
By Therapeutic Area
- Oncology
- Cardiovascular Disease
- Infectious Disease
- Neurological Disorders
- Other Therapeutic Area
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Biosimulation Market, by Product
1.4.2 LAMEA Biosimulation Market, by Pricing Model
1.4.3 LAMEA Biosimulation Market, by End Use
1.4.4 LAMEA Biosimulation Market, by Application
1.4.5 LAMEA Biosimulation Market, by Deployment Model
1.4.6 LAMEA Biosimulation Market, by Therapeutic Area
1.4.7 LAMEA Biosimulation Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2023
4.2 Strategies Deployed in Biosimulation Market
4.3 Porter Five Forces Analysis
Chapter 5. LAMEA Biosimulation Market by Product
5.1 LAMEA Software Market by Country
5.2 LAMEA Biosimulation Market by Software Type
5.2.1 LAMEA Molecular Modeling & Simulation Software Market by Country
5.2.2 LAMEA Clinical Trial Design Software Market by Country
5.2.3 LAMEA PK/PD Modeling and Simulation Software Market by Country
5.2.4 LAMEA Pbpk Modeling and Simulation Software Market by Country
5.2.5 LAMEA Toxicity Prediction Software Market by Country
5.2.6 LAMEA Other Software Type Market by Country
5.3 LAMEA Services Market by Country
5.4 LAMEA Biosimulation Market by Services Type
5.4.1 LAMEA Contract Services Market by Country
5.4.2 LAMEA Consulting Market by Country
5.4.3 LAMEA Other Services Type Market by Country
Chapter 6. LAMEA Biosimulation Market by Pricing Model
6.1 LAMEA License-based Model Market by Country
6.2 LAMEA Subscription-based Model Market by Country
6.3 LAMEA Service-based Model Market by Country
6.4 LAMEA Pay Per Use Model Market by Country
Chapter 7. LAMEA Biosimulation Market by End Use
7.1 LAMEA Life Sciences Companies Market by Country
7.2 LAMEA Academic Research Institutions Market by Country
7.3 LAMEA Other End Use Market by Country
Chapter 8. LAMEA Biosimulation Market by Application
8.1 LAMEA Drug Discovery & Development Market by Country
8.2 LAMEA Disease Modeling Market by Country
8.3 LAMEA Other Application Market by Country
Chapter 9. LAMEA Biosimulation Market by Deployment Model
9.1 LAMEA Cloud-based Market by Country
9.2 LAMEA On-premises Market by Country
9.3 LAMEA Hybrid Model Market by Country
Chapter 10. LAMEA Biosimulation Market by Therapeutic Area
10.1 LAMEA Oncology Market by Country
10.2 LAMEA Cardiovascular Disease Market by Country
10.3 LAMEA Infectious Disease Market by Country
10.4 LAMEA Neurological Disorders Market by Country
10.5 LAMEA Other Therapeutic Area Market by Country
Chapter 11. LAMEA Biosimulation Market by Country
11.1 Brazil Biosimulation Market
11.1.1 Brazil iosimulation Market by Product
11.1.1.1 Brazil Biosimulation Market by Software Type
11.1.1.2 Brazil Biosimulation Market by Services Type
11.1.2 Brazil Biosimulation Market by Pricing Model
11.1.3 Brazil Biosimulation Market by End Use
11.1.4 Brazil Biosimulation Market by Application
11.1.5 Brazil Biosimulation Market by Deployment Model
11.1.6 Brazil Biosimulation Market by Therapeutic Area
11.2 Argentina Biosimulation Market
11.2.1 Argentina Biosimulation Market by Product
11.2.1.1 Argentina Biosimulation Market by Software Type
11.2.1.2 Argentina Biosimulation Market by Services Type
11.2.2 Argentina Biosimulation Market by Pricing Model
11.2.3 Argentina Biosimulation Market by End Use
11.2.4 Argentina Biosimulation Market by Application
11.2.5 Argentina Biosimulation Market by Deployment Model
11.2.6 Argentina Biosimulation Market by Therapeutic Area
11.3 UAE Biosimulation Market
11.3.1 UAE Biosimulation Market by Product
11.3.1.1 UAE Biosimulation Market by Software Type
11.3.1.2 UAE Biosimulation Market by Services Type
11.3.2 UAE Biosimulation Market by Pricing Model
11.3.3 UAE Biosimulation Market by End Use
11.3.4 UAE Biosimulation Market by Application
11.3.5 UAE Biosimulation Market by Deployment Model
11.3.6 UAE Biosimulation Market by Therapeutic Area
11.4 Saudi Arabia Biosimulation Market
11.4.1 Saudi Arabia Biosimulation Market by Product
11.4.1.1 Saudi Arabia Biosimulation Market by Software Type
11.4.1.2 Saudi Arabia Biosimulation Market by Services Type
11.4.2 Saudi Arabia Biosimulation Market by Pricing Model
11.4.3 Saudi Arabia Biosimulation Market by End Use
11.4.4 Saudi Arabia Biosimulation Market by Application
11.4.5 Saudi Arabia Biosimulation Market by Deployment Model
11.4.6 Saudi Arabia Biosimulation Market by Therapeutic Area
11.5 South Africa Biosimulation Market
11.5.1 South Africa Biosimulation Market by Product
11.5.1.1 South Africa Biosimulation Market by Software Type
11.5.1.2 South Africa Biosimulation Market by Services Type
11.5.2 South Africa Biosimulation Market by Pricing Model
11.5.3 South Africa Biosimulation Market by End Use
11.5.4 South Africa Biosimulation Market by Application
11.5.5 South Africa Biosimulation Market by Deployment Model
11.5.6 South Africa Biosimulation Market by Therapeutic Area
11.6 Nigeria Biosimulation Market
11.6.1 Nigeria Biosimulation Market by Product
11.6.1.1 Nigeria Biosimulation Market by Software Type
11.6.1.2 Nigeria Biosimulation Market by Services Type
11.6.2 Nigeria Biosimulation Market by Pricing Model
11.6.3 Nigeria Biosimulation Market by End Use
11.6.4 Nigeria Biosimulation Market by Application
11.6.5 Nigeria Biosimulation Market by Deployment Model
11.6.6 Nigeria Biosimulation Market by Therapeutic Area
11.7 Rest of LAMEA Biosimulation Market
11.7.1 Rest of LAMEA Biosimulation Market by Product
11.7.1.1 Rest of LAMEA Biosimulation Market by Software Type
11.7.1.2 Rest of LAMEA Biosimulation Market by Services Type
11.7.2 Rest of LAMEA Biosimulation Market by Pricing Model
11.7.3 Rest of LAMEA Biosimulation Market by End Use
11.7.4 Rest of LAMEA Biosimulation Market by Application
11.7.5 Rest of LAMEA Biosimulation Market by Deployment Model
11.7.6 Rest of LAMEA Biosimulation Market by Therapeutic Area
Chapter 12. Company Profiles
12.1 Certara, Inc.
12.1.1 Company Overview
12.1.2 Financial Analysis
12.1.3 Regional Analysis
12.1.4 Research & Development Expenses
12.1.5 Recent strategies and developments:
12.1.5.1 Product Launches and Product Expansions:
12.1.5.2 Acquisition and Mergers:
12.1.6 SWOT Analysis
12.2 Dassault Systemes SE
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Regional Analysis
12.2.4 Research & Development Expense
12.2.5 SWOT Analysis
12.3 Advanced Chemistry Development, Inc.
12.3.1 Company Overview
12.4 Genedata AG (Danaher Corporation)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.5 Instem Group of Companies
12.5.1 Company Overview
12.6 Chemical Computing Group ULC
12.6.1 Company Overview
12.7 Simulations Plus, Inc.
12.7.1 Company Overview
12.7.2 Financial Analysis
12.7.3 Segmental and Regional Analysis
12.7.4 Research & Development Expenses
12.7.5 Recent strategies and developments:
12.7.5.1 Partnerships, Collaborations, and Agreements:
12.7.5.2 Product Launches and Product Expansions:
12.7.5.3 Acquisition and Mergers:
12.7.6 SWOT Analysis
12.8 Schrodinger, Inc.
12.8.1 Company Overview
12.8.2 Financial Analysis
12.8.3 Segmental and Regional Analysis
12.8.4 Research & Development Expenses
12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.10. Physiomics Plc
12.10.1 Company Overview
12.10.2 Financial Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Biosimulation Market, by Product
1.4.2 LAMEA Biosimulation Market, by Pricing Model
1.4.3 LAMEA Biosimulation Market, by End Use
1.4.4 LAMEA Biosimulation Market, by Application
1.4.5 LAMEA Biosimulation Market, by Deployment Model
1.4.6 LAMEA Biosimulation Market, by Therapeutic Area
1.4.7 LAMEA Biosimulation Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2023
4.2 Strategies Deployed in Biosimulation Market
4.3 Porter Five Forces Analysis
Chapter 5. LAMEA Biosimulation Market by Product
5.1 LAMEA Software Market by Country
5.2 LAMEA Biosimulation Market by Software Type
5.2.1 LAMEA Molecular Modeling & Simulation Software Market by Country
5.2.2 LAMEA Clinical Trial Design Software Market by Country
5.2.3 LAMEA PK/PD Modeling and Simulation Software Market by Country
5.2.4 LAMEA Pbpk Modeling and Simulation Software Market by Country
5.2.5 LAMEA Toxicity Prediction Software Market by Country
5.2.6 LAMEA Other Software Type Market by Country
5.3 LAMEA Services Market by Country
5.4 LAMEA Biosimulation Market by Services Type
5.4.1 LAMEA Contract Services Market by Country
5.4.2 LAMEA Consulting Market by Country
5.4.3 LAMEA Other Services Type Market by Country
Chapter 6. LAMEA Biosimulation Market by Pricing Model
6.1 LAMEA License-based Model Market by Country
6.2 LAMEA Subscription-based Model Market by Country
6.3 LAMEA Service-based Model Market by Country
6.4 LAMEA Pay Per Use Model Market by Country
Chapter 7. LAMEA Biosimulation Market by End Use
7.1 LAMEA Life Sciences Companies Market by Country
7.2 LAMEA Academic Research Institutions Market by Country
7.3 LAMEA Other End Use Market by Country
Chapter 8. LAMEA Biosimulation Market by Application
8.1 LAMEA Drug Discovery & Development Market by Country
8.2 LAMEA Disease Modeling Market by Country
8.3 LAMEA Other Application Market by Country
Chapter 9. LAMEA Biosimulation Market by Deployment Model
9.1 LAMEA Cloud-based Market by Country
9.2 LAMEA On-premises Market by Country
9.3 LAMEA Hybrid Model Market by Country
Chapter 10. LAMEA Biosimulation Market by Therapeutic Area
10.1 LAMEA Oncology Market by Country
10.2 LAMEA Cardiovascular Disease Market by Country
10.3 LAMEA Infectious Disease Market by Country
10.4 LAMEA Neurological Disorders Market by Country
10.5 LAMEA Other Therapeutic Area Market by Country
Chapter 11. LAMEA Biosimulation Market by Country
11.1 Brazil Biosimulation Market
11.1.1 Brazil iosimulation Market by Product
11.1.1.1 Brazil Biosimulation Market by Software Type
11.1.1.2 Brazil Biosimulation Market by Services Type
11.1.2 Brazil Biosimulation Market by Pricing Model
11.1.3 Brazil Biosimulation Market by End Use
11.1.4 Brazil Biosimulation Market by Application
11.1.5 Brazil Biosimulation Market by Deployment Model
11.1.6 Brazil Biosimulation Market by Therapeutic Area
11.2 Argentina Biosimulation Market
11.2.1 Argentina Biosimulation Market by Product
11.2.1.1 Argentina Biosimulation Market by Software Type
11.2.1.2 Argentina Biosimulation Market by Services Type
11.2.2 Argentina Biosimulation Market by Pricing Model
11.2.3 Argentina Biosimulation Market by End Use
11.2.4 Argentina Biosimulation Market by Application
11.2.5 Argentina Biosimulation Market by Deployment Model
11.2.6 Argentina Biosimulation Market by Therapeutic Area
11.3 UAE Biosimulation Market
11.3.1 UAE Biosimulation Market by Product
11.3.1.1 UAE Biosimulation Market by Software Type
11.3.1.2 UAE Biosimulation Market by Services Type
11.3.2 UAE Biosimulation Market by Pricing Model
11.3.3 UAE Biosimulation Market by End Use
11.3.4 UAE Biosimulation Market by Application
11.3.5 UAE Biosimulation Market by Deployment Model
11.3.6 UAE Biosimulation Market by Therapeutic Area
11.4 Saudi Arabia Biosimulation Market
11.4.1 Saudi Arabia Biosimulation Market by Product
11.4.1.1 Saudi Arabia Biosimulation Market by Software Type
11.4.1.2 Saudi Arabia Biosimulation Market by Services Type
11.4.2 Saudi Arabia Biosimulation Market by Pricing Model
11.4.3 Saudi Arabia Biosimulation Market by End Use
11.4.4 Saudi Arabia Biosimulation Market by Application
11.4.5 Saudi Arabia Biosimulation Market by Deployment Model
11.4.6 Saudi Arabia Biosimulation Market by Therapeutic Area
11.5 South Africa Biosimulation Market
11.5.1 South Africa Biosimulation Market by Product
11.5.1.1 South Africa Biosimulation Market by Software Type
11.5.1.2 South Africa Biosimulation Market by Services Type
11.5.2 South Africa Biosimulation Market by Pricing Model
11.5.3 South Africa Biosimulation Market by End Use
11.5.4 South Africa Biosimulation Market by Application
11.5.5 South Africa Biosimulation Market by Deployment Model
11.5.6 South Africa Biosimulation Market by Therapeutic Area
11.6 Nigeria Biosimulation Market
11.6.1 Nigeria Biosimulation Market by Product
11.6.1.1 Nigeria Biosimulation Market by Software Type
11.6.1.2 Nigeria Biosimulation Market by Services Type
11.6.2 Nigeria Biosimulation Market by Pricing Model
11.6.3 Nigeria Biosimulation Market by End Use
11.6.4 Nigeria Biosimulation Market by Application
11.6.5 Nigeria Biosimulation Market by Deployment Model
11.6.6 Nigeria Biosimulation Market by Therapeutic Area
11.7 Rest of LAMEA Biosimulation Market
11.7.1 Rest of LAMEA Biosimulation Market by Product
11.7.1.1 Rest of LAMEA Biosimulation Market by Software Type
11.7.1.2 Rest of LAMEA Biosimulation Market by Services Type
11.7.2 Rest of LAMEA Biosimulation Market by Pricing Model
11.7.3 Rest of LAMEA Biosimulation Market by End Use
11.7.4 Rest of LAMEA Biosimulation Market by Application
11.7.5 Rest of LAMEA Biosimulation Market by Deployment Model
11.7.6 Rest of LAMEA Biosimulation Market by Therapeutic Area
Chapter 12. Company Profiles
12.1 Certara, Inc.
12.1.1 Company Overview
12.1.2 Financial Analysis
12.1.3 Regional Analysis
12.1.4 Research & Development Expenses
12.1.5 Recent strategies and developments:
12.1.5.1 Product Launches and Product Expansions:
12.1.5.2 Acquisition and Mergers:
12.1.6 SWOT Analysis
12.2 Dassault Systemes SE
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Regional Analysis
12.2.4 Research & Development Expense
12.2.5 SWOT Analysis
12.3 Advanced Chemistry Development, Inc.
12.3.1 Company Overview
12.4 Genedata AG (Danaher Corporation)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.5 Instem Group of Companies
12.5.1 Company Overview
12.6 Chemical Computing Group ULC
12.6.1 Company Overview
12.7 Simulations Plus, Inc.
12.7.1 Company Overview
12.7.2 Financial Analysis
12.7.3 Segmental and Regional Analysis
12.7.4 Research & Development Expenses
12.7.5 Recent strategies and developments:
12.7.5.1 Partnerships, Collaborations, and Agreements:
12.7.5.2 Product Launches and Product Expansions:
12.7.5.3 Acquisition and Mergers:
12.7.6 SWOT Analysis
12.8 Schrodinger, Inc.
12.8.1 Company Overview
12.8.2 Financial Analysis
12.8.3 Segmental and Regional Analysis
12.8.4 Research & Development Expenses
12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.10. Physiomics Plc
12.10.1 Company Overview
12.10.2 Financial Analysis
List of Tables
TABLE 1 LAMEA Biosimulation Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Biosimulation Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 4 LAMEA Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 5 LAMEA Software Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Software Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 8 LAMEA Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 9 LAMEA Molecular Modeling & Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Molecular Modeling & Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Clinical Trial Design Software Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Clinical Trial Design Software Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA PK/PD Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA PK/PD Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Pbpk Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Pbpk Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Toxicity Prediction Software Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Toxicity Prediction Software Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Other Software Type Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Other Software Type Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Services Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA Services Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 24 LAMEA Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 25 LAMEA Contract Services Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Contract Services Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Consulting Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Consulting Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Other Services Type Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Other Services Type Market by Country, 2024 - 2031, USD Million
TABLE 31 LAMEA Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 32 LAMEA Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 33 LAMEA License-based Model Market by Country, 2020 - 2023, USD Million
TABLE 34 LAMEA License-based Model Market by Country, 2024 - 2031, USD Million
TABLE 35 LAMEA Subscription-based Model Market by Country, 2020 - 2023, USD Million
TABLE 36 LAMEA Subscription-based Model Market by Country, 2024 - 2031, USD Million
TABLE 37 LAMEA Service-based Model Market by Country, 2020 - 2023, USD Million
TABLE 38 LAMEA Service-based Model Market by Country, 2024 - 2031, USD Million
TABLE 39 LAMEA Pay Per Use Model Market by Country, 2020 - 2023, USD Million
TABLE 40 LAMEA Pay Per Use Model Market by Country, 2024 - 2031, USD Million
TABLE 41 LAMEA Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 42 LAMEA Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 43 LAMEA Life Sciences Companies Market by Country, 2020 - 2023, USD Million
TABLE 44 LAMEA Life Sciences Companies Market by Country, 2024 - 2031, USD Million
TABLE 45 LAMEA Academic Research Institutions Market by Country, 2020 - 2023, USD Million
TABLE 46 LAMEA Academic Research Institutions Market by Country, 2024 - 2031, USD Million
TABLE 47 LAMEA Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 48 LAMEA Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 49 LAMEA Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 50 LAMEA Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 51 LAMEA Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 52 LAMEA Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 53 LAMEA Disease Modeling Market by Country, 2020 - 2023, USD Million
TABLE 54 LAMEA Disease Modeling Market by Country, 2024 - 2031, USD Million
TABLE 55 LAMEA Other Application Market by Country, 2020 - 2023, USD Million
TABLE 56 LAMEA Other Application Market by Country, 2024 - 2031, USD Million
TABLE 57 LAMEA Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 58 LAMEA Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 59 LAMEA Cloud-based Market by Country, 2020 - 2023, USD Million
TABLE 60 LAMEA Cloud-based Market by Country, 2024 - 2031, USD Million
TABLE 61 LAMEA On-premises Market by Country, 2020 - 2023, USD Million
TABLE 62 LAMEA On-premises Market by Country, 2024 - 2031, USD Million
TABLE 63 LAMEA Hybrid Model Market by Country, 2020 - 2023, USD Million
TABLE 64 LAMEA Hybrid Model Market by Country, 2024 - 2031, USD Million
TABLE 65 LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 66 LAMEA Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 67 LAMEA Oncology Market by Country, 2020 - 2023, USD Million
TABLE 68 LAMEA Oncology Market by Country, 2024 - 2031, USD Million
TABLE 69 LAMEA Cardiovascular Disease Market by Country, 2020 - 2023, USD Million
TABLE 70 LAMEA Cardiovascular Disease Market by Country, 2024 - 2031, USD Million
TABLE 71 LAMEA Infectious Disease Market by Country, 2020 - 2023, USD Million
TABLE 72 LAMEA Infectious Disease Market by Country, 2024 - 2031, USD Million
TABLE 73 LAMEA Neurological Disorders Market by Country, 2020 - 2023, USD Million
TABLE 74 LAMEA Neurological Disorders Market by Country, 2024 - 2031, USD Million
TABLE 75 LAMEA Other Therapeutic Area Market by Country, 2020 - 2023, USD Million
TABLE 76 LAMEA Other Therapeutic Area Market by Country, 2024 - 2031, USD Million
TABLE 77 LAMEA Biosimulation Market by Country, 2020 - 2023, USD Million
TABLE 78 LAMEA Biosimulation Market by Country, 2024 - 2031, USD Million
TABLE 79 Brazil Biosimulation Market, 2020 - 2023, USD Million
TABLE 80 Brazil Biosimulation Market, 2024 - 2031, USD Million
TABLE 81 Brazil Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 82 Brazil Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 83 Brazil Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 84 Brazil Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 85 Brazil Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 86 Brazil Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 87 Brazil Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 88 Brazil Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 89 Brazil Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 90 Brazil Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 91 Brazil Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 92 Brazil Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 93 Brazil Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 94 Brazil Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 95 Brazil Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 96 Brazil Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 97 Argentina Biosimulation Market, 2020 - 2023, USD Million
TABLE 98 Argentina Biosimulation Market, 2024 - 2031, USD Million
TABLE 99 Argentina Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 100 Argentina Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 101 Argentina Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 102 Argentina Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 103 Argentina Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 104 Argentina Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 105 Argentina Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 106 Argentina Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 107 Argentina Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 108 Argentina Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 109 Argentina Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 110 Argentina Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 111 Argentina Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 112 Argentina Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 113 Argentina Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 114 Argentina Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 115 UAE Biosimulation Market, 2020 - 2023, USD Million
TABLE 116 UAE Biosimulation Market, 2024 - 2031, USD Million
TABLE 117 UAE Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 118 UAE Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 119 UAE Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 120 UAE Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 121 UAE Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 122 UAE Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 123 UAE Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 124 UAE Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 125 UAE Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 126 UAE Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 127 UAE Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 128 UAE Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 129 UAE Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 130 UAE Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 131 UAE Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 132 UAE Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 133 Saudi Arabia Biosimulation Market, 2020 - 2023, USD Million
TABLE 134 Saudi Arabia Biosimulation Market, 2024 - 2031, USD Million
TABLE 135 Saudi Arabia Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 136 Saudi Arabia Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 137 Saudi Arabia Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 138 Saudi Arabia Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 139 Saudi Arabia Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 140 Saudi Arabia Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 141 Saudi Arabia Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 142 Saudi Arabia Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 143 Saudi Arabia Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 144 Saudi Arabia Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 145 Saudi Arabia Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 146 Saudi Arabia Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 147 Saudi Arabia Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 148 Saudi Arabia Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 149 Saudi Arabia Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 150 Saudi Arabia Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 151 South Africa Biosimulation Market, 2020 - 2023, USD Million
TABLE 152 South Africa Biosimulation Market, 2024 - 2031, USD Million
TABLE 153 South Africa Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 154 South Africa Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 155 South Africa Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 156 South Africa Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 157 South Africa Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 158 South Africa Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 159 South Africa Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 160 South Africa Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 161 South Africa Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 162 South Africa Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 163 South Africa Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 164 South Africa Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 165 South Africa Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 166 South Africa Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 167 South Africa Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 168 South Africa Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 169 Nigeria Biosimulation Market, 2020 - 2023, USD Million
TABLE 170 Nigeria Biosimulation Market, 2024 - 2031, USD Million
TABLE 171 Nigeria Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 172 Nigeria Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 173 Nigeria Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 174 Nigeria Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 175 Nigeria Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 176 Nigeria Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 177 Nigeria Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 178 Nigeria Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 179 Nigeria Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 180 Nigeria Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 181 Nigeria Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 182 Nigeria Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 183 Nigeria Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 184 Nigeria Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 185 Nigeria Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 186 Nigeria Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 187 Rest of LAMEA Biosimulation Market, 2020 - 2023, USD Million
TABLE 188 Rest of LAMEA Biosimulation Market, 2024 - 2031, USD Million
TABLE 189 Rest of LAMEA Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 190 Rest of LAMEA Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 191 Rest of LAMEA Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 192 Rest of LAMEA Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 193 Rest of LAMEA Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 194 Rest of LAMEA Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 195 Rest of LAMEA Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 196 Rest of LAMEA Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 197 Rest of LAMEA Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 198 Rest of LAMEA Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 199 Rest of LAMEA Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 200 Rest of LAMEA Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 201 Rest of LAMEA Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 202 Rest of LAMEA Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 203 Rest of LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 204 Rest of LAMEA Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 205 Key Information – Certara, Inc.
TABLE 206 Key Information – Dassault Systemes SE
TABLE 207 Key Information – Advanced Chemistry Development, Inc.
TABLE 208 Key Information – Genedata AG
TABLE 209 Key Information – Instem Group of Companies
TABLE 210 Key Information – Chemical Computing Group ULC
TABLE 211 Key Information – Simulations Plus, Inc.
TABLE 212 Key Information – Schrodinger, Inc.
TABLE 213 Key Information – PPD, Inc.
TABLE 214 Key Information – Physiomics Plc
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Biosimulation Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Biosimulation Market
FIG 4 Market Share Analysis, 2023
FIG 5 Porter’s Five Forces Analysis – Biosimulation Market
FIG 6 LAMEA Biosimulation Market share by Product, 2023
FIG 7 LAMEA Biosimulation Market share by Product, 2031
FIG 8 LAMEA Biosimulation Market by Product, 2020 - 2031, USD Million
FIG 9 LAMEA Biosimulation Market share by Pricing Model, 2023
FIG 10 LAMEA Biosimulation Market share by Pricing Model, 2031
FIG 11 LAMEA Biosimulation Market by Pricing Model, 2020 - 2031, USD Million
FIG 12 LAMEA Biosimulation Market share by End Use, 2023
FIG 13 LAMEA Biosimulation Market share by End Use, 2031
FIG 14 LAMEA Biosimulation Market by End Use, 2020 - 2031, USD Million
FIG 15 LAMEA Biosimulation Market share by Application, 2023
FIG 16 LAMEA Biosimulation Market share by Application, 2031
FIG 17 LAMEA Biosimulation Market by Application, 2020 - 2031, USD Million
FIG 18 LAMEA Biosimulation Market share by Deployment Model, 2023
FIG 19 LAMEA Biosimulation Market share by Deployment Model, 2031
FIG 20 LAMEA Biosimulation Market by Deployment Model, 2020 - 2031, USD Million
FIG 21 LAMEA Biosimulation Market share by Therapeutic Area, 2023
FIG 22 LAMEA Biosimulation Market share by Therapeutic Area, 2031
FIG 23 LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2031, USD Million
FIG 24 LAMEA Biosimulation Market share by Country, 2023
FIG 25 LAMEA Biosimulation Market share by Country, 2031
FIG 26 LAMEA Biosimulation Market by Country, 2020 - 2031, USD Million
FIG 27 Recent strategies and developments: Certara, Inc.
FIG 28 Swot Analysis: Certara, Inc.
FIG 29 SWOT Analysis: Dassault Systemes SE
FIG 30 Recent strategies and developments: Simulations Plus, Inc.
FIG 31 Swot Analysis: Simulation Plus, Inc.
TABLE 2 LAMEA Biosimulation Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 4 LAMEA Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 5 LAMEA Software Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Software Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 8 LAMEA Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 9 LAMEA Molecular Modeling & Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Molecular Modeling & Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Clinical Trial Design Software Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Clinical Trial Design Software Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA PK/PD Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA PK/PD Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Pbpk Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Pbpk Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Toxicity Prediction Software Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Toxicity Prediction Software Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Other Software Type Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Other Software Type Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Services Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA Services Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 24 LAMEA Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 25 LAMEA Contract Services Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Contract Services Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Consulting Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Consulting Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Other Services Type Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Other Services Type Market by Country, 2024 - 2031, USD Million
TABLE 31 LAMEA Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 32 LAMEA Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 33 LAMEA License-based Model Market by Country, 2020 - 2023, USD Million
TABLE 34 LAMEA License-based Model Market by Country, 2024 - 2031, USD Million
TABLE 35 LAMEA Subscription-based Model Market by Country, 2020 - 2023, USD Million
TABLE 36 LAMEA Subscription-based Model Market by Country, 2024 - 2031, USD Million
TABLE 37 LAMEA Service-based Model Market by Country, 2020 - 2023, USD Million
TABLE 38 LAMEA Service-based Model Market by Country, 2024 - 2031, USD Million
TABLE 39 LAMEA Pay Per Use Model Market by Country, 2020 - 2023, USD Million
TABLE 40 LAMEA Pay Per Use Model Market by Country, 2024 - 2031, USD Million
TABLE 41 LAMEA Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 42 LAMEA Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 43 LAMEA Life Sciences Companies Market by Country, 2020 - 2023, USD Million
TABLE 44 LAMEA Life Sciences Companies Market by Country, 2024 - 2031, USD Million
TABLE 45 LAMEA Academic Research Institutions Market by Country, 2020 - 2023, USD Million
TABLE 46 LAMEA Academic Research Institutions Market by Country, 2024 - 2031, USD Million
TABLE 47 LAMEA Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 48 LAMEA Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 49 LAMEA Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 50 LAMEA Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 51 LAMEA Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 52 LAMEA Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 53 LAMEA Disease Modeling Market by Country, 2020 - 2023, USD Million
TABLE 54 LAMEA Disease Modeling Market by Country, 2024 - 2031, USD Million
TABLE 55 LAMEA Other Application Market by Country, 2020 - 2023, USD Million
TABLE 56 LAMEA Other Application Market by Country, 2024 - 2031, USD Million
TABLE 57 LAMEA Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 58 LAMEA Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 59 LAMEA Cloud-based Market by Country, 2020 - 2023, USD Million
TABLE 60 LAMEA Cloud-based Market by Country, 2024 - 2031, USD Million
TABLE 61 LAMEA On-premises Market by Country, 2020 - 2023, USD Million
TABLE 62 LAMEA On-premises Market by Country, 2024 - 2031, USD Million
TABLE 63 LAMEA Hybrid Model Market by Country, 2020 - 2023, USD Million
TABLE 64 LAMEA Hybrid Model Market by Country, 2024 - 2031, USD Million
TABLE 65 LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 66 LAMEA Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 67 LAMEA Oncology Market by Country, 2020 - 2023, USD Million
TABLE 68 LAMEA Oncology Market by Country, 2024 - 2031, USD Million
TABLE 69 LAMEA Cardiovascular Disease Market by Country, 2020 - 2023, USD Million
TABLE 70 LAMEA Cardiovascular Disease Market by Country, 2024 - 2031, USD Million
TABLE 71 LAMEA Infectious Disease Market by Country, 2020 - 2023, USD Million
TABLE 72 LAMEA Infectious Disease Market by Country, 2024 - 2031, USD Million
TABLE 73 LAMEA Neurological Disorders Market by Country, 2020 - 2023, USD Million
TABLE 74 LAMEA Neurological Disorders Market by Country, 2024 - 2031, USD Million
TABLE 75 LAMEA Other Therapeutic Area Market by Country, 2020 - 2023, USD Million
TABLE 76 LAMEA Other Therapeutic Area Market by Country, 2024 - 2031, USD Million
TABLE 77 LAMEA Biosimulation Market by Country, 2020 - 2023, USD Million
TABLE 78 LAMEA Biosimulation Market by Country, 2024 - 2031, USD Million
TABLE 79 Brazil Biosimulation Market, 2020 - 2023, USD Million
TABLE 80 Brazil Biosimulation Market, 2024 - 2031, USD Million
TABLE 81 Brazil Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 82 Brazil Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 83 Brazil Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 84 Brazil Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 85 Brazil Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 86 Brazil Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 87 Brazil Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 88 Brazil Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 89 Brazil Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 90 Brazil Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 91 Brazil Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 92 Brazil Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 93 Brazil Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 94 Brazil Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 95 Brazil Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 96 Brazil Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 97 Argentina Biosimulation Market, 2020 - 2023, USD Million
TABLE 98 Argentina Biosimulation Market, 2024 - 2031, USD Million
TABLE 99 Argentina Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 100 Argentina Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 101 Argentina Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 102 Argentina Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 103 Argentina Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 104 Argentina Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 105 Argentina Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 106 Argentina Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 107 Argentina Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 108 Argentina Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 109 Argentina Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 110 Argentina Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 111 Argentina Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 112 Argentina Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 113 Argentina Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 114 Argentina Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 115 UAE Biosimulation Market, 2020 - 2023, USD Million
TABLE 116 UAE Biosimulation Market, 2024 - 2031, USD Million
TABLE 117 UAE Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 118 UAE Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 119 UAE Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 120 UAE Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 121 UAE Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 122 UAE Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 123 UAE Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 124 UAE Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 125 UAE Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 126 UAE Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 127 UAE Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 128 UAE Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 129 UAE Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 130 UAE Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 131 UAE Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 132 UAE Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 133 Saudi Arabia Biosimulation Market, 2020 - 2023, USD Million
TABLE 134 Saudi Arabia Biosimulation Market, 2024 - 2031, USD Million
TABLE 135 Saudi Arabia Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 136 Saudi Arabia Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 137 Saudi Arabia Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 138 Saudi Arabia Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 139 Saudi Arabia Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 140 Saudi Arabia Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 141 Saudi Arabia Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 142 Saudi Arabia Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 143 Saudi Arabia Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 144 Saudi Arabia Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 145 Saudi Arabia Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 146 Saudi Arabia Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 147 Saudi Arabia Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 148 Saudi Arabia Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 149 Saudi Arabia Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 150 Saudi Arabia Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 151 South Africa Biosimulation Market, 2020 - 2023, USD Million
TABLE 152 South Africa Biosimulation Market, 2024 - 2031, USD Million
TABLE 153 South Africa Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 154 South Africa Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 155 South Africa Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 156 South Africa Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 157 South Africa Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 158 South Africa Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 159 South Africa Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 160 South Africa Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 161 South Africa Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 162 South Africa Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 163 South Africa Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 164 South Africa Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 165 South Africa Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 166 South Africa Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 167 South Africa Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 168 South Africa Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 169 Nigeria Biosimulation Market, 2020 - 2023, USD Million
TABLE 170 Nigeria Biosimulation Market, 2024 - 2031, USD Million
TABLE 171 Nigeria Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 172 Nigeria Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 173 Nigeria Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 174 Nigeria Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 175 Nigeria Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 176 Nigeria Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 177 Nigeria Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 178 Nigeria Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 179 Nigeria Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 180 Nigeria Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 181 Nigeria Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 182 Nigeria Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 183 Nigeria Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 184 Nigeria Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 185 Nigeria Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 186 Nigeria Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 187 Rest of LAMEA Biosimulation Market, 2020 - 2023, USD Million
TABLE 188 Rest of LAMEA Biosimulation Market, 2024 - 2031, USD Million
TABLE 189 Rest of LAMEA Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 190 Rest of LAMEA Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 191 Rest of LAMEA Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 192 Rest of LAMEA Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 193 Rest of LAMEA Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 194 Rest of LAMEA Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 195 Rest of LAMEA Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 196 Rest of LAMEA Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 197 Rest of LAMEA Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 198 Rest of LAMEA Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 199 Rest of LAMEA Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 200 Rest of LAMEA Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 201 Rest of LAMEA Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 202 Rest of LAMEA Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 203 Rest of LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 204 Rest of LAMEA Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 205 Key Information – Certara, Inc.
TABLE 206 Key Information – Dassault Systemes SE
TABLE 207 Key Information – Advanced Chemistry Development, Inc.
TABLE 208 Key Information – Genedata AG
TABLE 209 Key Information – Instem Group of Companies
TABLE 210 Key Information – Chemical Computing Group ULC
TABLE 211 Key Information – Simulations Plus, Inc.
TABLE 212 Key Information – Schrodinger, Inc.
TABLE 213 Key Information – PPD, Inc.
TABLE 214 Key Information – Physiomics Plc
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Biosimulation Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Biosimulation Market
FIG 4 Market Share Analysis, 2023
FIG 5 Porter’s Five Forces Analysis – Biosimulation Market
FIG 6 LAMEA Biosimulation Market share by Product, 2023
FIG 7 LAMEA Biosimulation Market share by Product, 2031
FIG 8 LAMEA Biosimulation Market by Product, 2020 - 2031, USD Million
FIG 9 LAMEA Biosimulation Market share by Pricing Model, 2023
FIG 10 LAMEA Biosimulation Market share by Pricing Model, 2031
FIG 11 LAMEA Biosimulation Market by Pricing Model, 2020 - 2031, USD Million
FIG 12 LAMEA Biosimulation Market share by End Use, 2023
FIG 13 LAMEA Biosimulation Market share by End Use, 2031
FIG 14 LAMEA Biosimulation Market by End Use, 2020 - 2031, USD Million
FIG 15 LAMEA Biosimulation Market share by Application, 2023
FIG 16 LAMEA Biosimulation Market share by Application, 2031
FIG 17 LAMEA Biosimulation Market by Application, 2020 - 2031, USD Million
FIG 18 LAMEA Biosimulation Market share by Deployment Model, 2023
FIG 19 LAMEA Biosimulation Market share by Deployment Model, 2031
FIG 20 LAMEA Biosimulation Market by Deployment Model, 2020 - 2031, USD Million
FIG 21 LAMEA Biosimulation Market share by Therapeutic Area, 2023
FIG 22 LAMEA Biosimulation Market share by Therapeutic Area, 2031
FIG 23 LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2031, USD Million
FIG 24 LAMEA Biosimulation Market share by Country, 2023
FIG 25 LAMEA Biosimulation Market share by Country, 2031
FIG 26 LAMEA Biosimulation Market by Country, 2020 - 2031, USD Million
FIG 27 Recent strategies and developments: Certara, Inc.
FIG 28 Swot Analysis: Certara, Inc.
FIG 29 SWOT Analysis: Dassault Systemes SE
FIG 30 Recent strategies and developments: Simulations Plus, Inc.
FIG 31 Swot Analysis: Simulation Plus, Inc.